Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

peptidoglycan complex of spirulina K-001

An orally bioavailable preparation of peptidoglycan derived from the fermentation product of the marine microorganism spirulina, with potential immunomodulating and antineoplastic activities. Upon oral administration, peptidoglycan complex of spirulina K-001 may activate the innate immune system. This may re-activate the immune system to exert an antitumor immune response.

Code name:	K 001 K-001 K001

peptidoglycan complex of spirulina K-001

Search NCI's Drug Dictionary